한글목차

대장암 진단의 동향과 예측

세계의 대장암 진단 시장은 2030년까지 추정 338억 달러에 달할 것으로 예측되고 있으며, 2024-2030년의 CAGR은 6.5%로 성장할 것으로 예측되고 있습니다. 이 시장의 주요 촉진요인은 암 질환의 유병률 증가, 인식 증가 및 조기 진단 방법, 의료비 지출 증가입니다. 세계 대장암 진단 시장의 미래는 병원, 진단센터, 암 연구센터, 외래수술센터(ASC) 시장에서의 기회로 인해 유망합니다.

대장암 진단 건수 부문별 추이

이 보고서는 대장암 진단의 제품 유형별, 암 유형별, 연령대별, 최종사용자별, 지역별 세계 예측을 담고 있습니다.

대장암 진단 시장 인사이트

• Lucintel의 예측에 따르면 암 진단을 위한 의료비 지출 증가와 예방 의료에 대한 선호도 증가로 인해 의료기기가 예측 기간 중 가장 높은 성장세를 보일 것으로 예상됩니다.
• 이 시장에서 진단센터는 대장암 질환에 대한 비용 효율적인 진단 시설에 대한 수요가 증가하고 전 세계 진단센터 수가 증가함에 따라 진단센터가 계속해서 가장 큰 부문이 될 것입니다.
• 북미는 첨단 진단 절차 및 진단 기술의 가용성과 대장암 진단 검사에 대한 수요 증가로 인해 예측 기간 중 가장 높은 성장세를 보일 것으로 예상됩니다.

자주 묻는 질문

Q.1 대장암 진단 시장 규모는?

A1. 세계 대장암 진단 시장은 2030년까지 338억 달러에 달할 것으로 추정됩니다.

Q.2 대장암 진단 시장의 성장 전망은?

A2. 세계 대장암 진단 시장은 2024-2030년 연평균 6.5%의 성장률을 보일 것으로 예상됩니다.

Q.3 대장암 진단 시장의 성장에 영향을 미치는 주요 촉진요인은 무엇인가?

A3.이 시장의 주요 촉진요인은 암 질환의 유병률 증가, 인식 개선, 조기 진단 방법, 의료비 지출 증가입니다.

Q4. 시장의 주요 부문은 다음과 같습니다.

대장암 진단 시장의 미래는 병원, 진단센터, 암 연구센터, 외래 수술센터 등 각 시장에서 기회가 많을 것으로 예상됩니다.

Q5. 시장 주요 기업은 다음과 같습니다.

대장암 진단 주요 기업은 다음과 같습니다.

• General Electric
• Siemens Healthcare
• Koninklijke Philips
• F. Hoffmann-La Roche
• Abbott
• Illumina
• Qiagen
• Thermo Fisher Scientific
• Quest Diagnostics
• Merck

Q6. 향후 가장 큰 시장 부문은 다음과 같습니다.

Lucintel은 암 진단을 위한 의료비 지출 증가와 예방 의료에 대한 선호도 증가로 인해 예측 기간 중 의료기기가 가장 높은 성장세를 보일 것으로 예상하고 있습니다.

Q7. 시장에서 향후 5년간 가장 큰 시장이 될 것으로 예상되는 지역은 어디입니까?

A7. 북미는 첨단 진단 절차와 기술이 발달하고 대장암 진단 검사에 대한 수요가 증가함에 따라 예측 기간 중 가장 높은 성장률을 보일 것으로 예상됩니다.

Q8. 보고서 사용자 정의가 가능합니까?

A8. 네. Lucintel은 추가 비용없이 10%의 사용자 정의를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 대장암 진단 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 2018-2030년의 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 대장암 진단 시장의 동향(2018-2023년)과 예측(2024-2030년)
• 제품 유형별 세계의 대장암 진단 시장
  • 기기
  • 소모품과 액세서리
• 암 종류별 대장암 진단 시장의 세계 규모
  • 선암
  • 대장 림프종
  • 위장관기질종양
  • 카르시노이드 종양
  • 기타
• 연령 그룹별 세계의 대장암 진단 시장
  • 노년
  • 성인
  • 소아
• 최종 용도별 세계의 대장암 진단 시장
  • 병원
  • 진단 센터
  • 암연구 센터
  • 외래 수술 센터
  • 기타

제4장 2018-2030년의 지역별 시장 동향과 예측 분석

• 지역별 대장암 진단 시장
• 북미의 대장암 진단 시장
• 유럽의 대장암 진단 시장
• 아시아태평양의 대장암 진단 시장
• 기타 지역의 대장암 진단 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 업무 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 제품 유형별 세계 대장암 진단 시장의 성장 기회
  • 암의 유형별 세계의 대장암 진단 시장의 성장 기회
  • 연령층별 세계의 대장암 진단 시장의 성장 기회
  • 최종 용도별 세계 대장암 진단 시장의 성장 기회
  • 지역별 세계의 대장암 진단 시장의 성장 기회
• 세계의 대장암 진단 시장의 새로운 동향
• 전략 분석
  • 신제품의 개발
  • 세계의 대장암 진단 시장의 능력 확대
  • 세계의 대장암 진단 시장에서의 합병, 인수, 합병사업
  • 인증과 라이선싱

제7장 주요 기업의 기업 개요

• General Electric
• Siemens Healthcare
• Koninklijke Philips
• F. Hoffmann-La Roche
• Abbott
• Illumina
• QIAGEN
• Thermo Fisher Scientific
• Quest Diagnostics
• Merck .

영문목차

Colorectal Cancer Diagnostic Trends and Forecast

The future of the global colorectal cancer diagnostic market looks promising with opportunities in the hospital, diagnostic center, cancer research center, and ambulatory surgical center markets.The global colorectal cancer diagnostic market is expected to reach an estimated $33.8 billion by 2030, and it is forecast to grow at a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing prevalence of cancer diseases, rising awareness and early diagnostic procedures, and increasing healthcare expenditure.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Colorectal Cancer Diagnostic by Segment

The study includes a forecast for the global colorectal cancer diagnostic by product type, cancer type, age group, end use, and region.

Colorectal Cancer Diagnostic Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Instruments
• Consumables & Accessories

Colorectal Cancer Diagnostic Market by Cancer Type [Shipment Analysis by Value from 2018 to 2030]:

• Adenocarcinoma
• Colorectal Lymphoma
• Gastrointestinal Stromal Tumors
• Carcinoid Tumors
• Others

Colorectal Cancer Diagnostic Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

• Geriatric
• Adults
• Pediatric

Colorectal Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Diagnostic Centers
• Cancer Research Centers
• Ambulatory Surgical Centers
• Others

Colorectal Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Colorectal Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies colorectal cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the colorectal cancer diagnostic companies profiled in this report include-

• General Electric
• Siemens Healthcare
• Koninklijke Philips
• F. Hoffmann-La Roche
• Abbott
• Illumina
• Qiagen
• Thermo Fisher Scientific
• Quest Diagnostics
• Merck

Colorectal Cancer Diagnostic Market Insights

• Lucintel forecasts that instruments is expected to witness highest growth over the forecast period due to the growing healthcare expenditure for cancer diagnosis and increasing preference for preventive healthcare measures.
• Within this market, diagnostic centers will remain the largest segment due to growing need for cost effective diagnosis facilities for colorectal cancer disease and rising number of diagnostic centers globally.
• North America is expected to witness highest growth over the forecast period due to availability of advanced diagnostic procedure and techniques and growing demand for colorectal cancer diagnostics testing.

Features of the Global Colorectal Cancer Diagnostic Market

• Market Size Estimates: Colorectal cancer diagnostic market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
• Segmentation Analysis: Colorectal cancer diagnostic market size by various segments, such as by product type, cancer type, age group, end use, and region in terms of ($B).
• Regional Analysis: Colorectal cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different product types, cancer types, age groups, end uses, and regions for the colorectal cancer diagnostic market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the colorectal cancer diagnostic market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the colorectal cancer diagnostic market size?

Answer: The global colorectal cancer diagnostic market is expected to reach an estimated $33.8 billion by 2030.

Q.2 What is the growth forecast for colorectal cancer diagnostic market?

Answer: The global colorectal cancer diagnostic market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the colorectal cancer diagnostic market?

Answer: The major drivers for this market are increasing prevalence of cancer diseases, rising awareness and early diagnostic procedures and increasing healthcare expenditure.

Q4. What are the major segments for colorectal cancer diagnostic market?

Answer: The future of the colorectal cancer diagnostic market looks promising with opportunities in the hospital, diagnostic center, cancer research center, and ambulatory surgical center markets.

Q5. Who are the key colorectal cancer diagnostic market companies?

Answer: Some of the key colorectal cancer diagnostic companies are as follows:

• General Electric
• Siemens Healthcare
• Koninklijke Philips
• F. Hoffmann-La Roche
• Abbott
• Illumina
• Qiagen
• Thermo Fisher Scientific
• Quest Diagnostics
• Merck

Q6. Which colorectal cancer diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that instruments is expected to witness highest growth over the forecast period due to the growing healthcare expenditure for cancer diagnosis and increasing preference for preventive healthcare measures.

Q7. In colorectal cancer diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to availability of advanced diagnostic procedure and techniques and growing demand for colorectal cancer diagnostics testing.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the colorectal cancer diagnostic market by product type (instruments and consumables & accessories), cancer type (adenocarcinoma, colorectal lymphoma, gastrointestinal stromal tumors, carcinoid tumors, and others), age group (geriatric, adults, and pediatric), end use (hospitals, diagnostic centers, cancer research centers, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Colorectal Cancer Diagnostic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1: Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2: Global Colorectal Cancer Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Colorectal Cancer Diagnostic Market by Product Type
  • 3.3.1: Instruments
  • 3.3.2: Consumables & Accessories
• 3.4: Global Colorectal Cancer Diagnostic Market by Cancer Type
  • 3.4.1: Adenocarcinoma
  • 3.4.2: Colorectal Lymphoma
  • 3.4.3: Gastrointestinal Stromal Tumors
  • 3.4.4: Carcinoid Tumors
  • 3.4.5: Others
• 3.5: Global Colorectal Cancer Diagnostic Market by Age Group
  • 3.5.1: Geriatric
  • 3.5.2: Adults
  • 3.5.3: Pediatric
• 3.6: Global Colorectal Cancer Diagnostic Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Diagnostic Centers
  • 3.6.3: Cancer Research Centers
  • 3.6.4: Ambulatory Surgical Centers
  • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Colorectal Cancer Diagnostic Market by Region
• 4.2: North American Colorectal Cancer Diagnostic Market
  • 4.2.1: North American Colorectal Cancer Diagnostic Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, and Others
• 4.3: European Colorectal Cancer Diagnostic Market
  • 4.3.1: European Colorectal Cancer Diagnostic Market by Product Type: Instruments and Consumables & Accessories
  • 4.3.2: European Colorectal Cancer Diagnostic Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, and Others
• 4.4: APAC Colorectal Cancer Diagnostic Market
  • 4.4.1: APAC Colorectal Cancer Diagnostic Market by Product Type: Instruments and Consumables & Accessories
  • 4.4.2: APAC Colorectal Cancer Diagnostic Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, and Others
• 4.5: ROW Colorectal Cancer Diagnostic Market
  • 4.5.1: ROW Colorectal Cancer Diagnostic Market by Product Type: Instruments and Consumables & Accessories
  • 4.5.2: ROW Colorectal Cancer Diagnostic Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by Cancer Type
  • 6.1.3: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by Age Group
  • 6.1.4: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by End Use
  • 6.1.5: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by Region
• 6.2: Emerging Trends in the Global Colorectal Cancer Diagnostic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Colorectal Cancer Diagnostic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Colorectal Cancer Diagnostic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: General Electric
• 7.2: Siemens Healthcare
• 7.3: Koninklijke Philips
• 7.4: F. Hoffmann-La Roche
• 7.5: Abbott
• 7.6: Illumina
• 7.7: QIAGEN
• 7.8: Thermo Fisher Scientific
• 7.9: Quest Diagnostics
• 7.10: Merck .